Original Source(s)
Related Content
OI Therapy Raised BMD, Not Fracture Benefit
Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.
June 5, 2026
-
7 min
Medical Oddities: The Economics of Shut-Eye
Sleep became a commodity, tea became a therapy, and cats got a reprieve this week.
by Teraya Smith
June 11, 2026
-
6 min
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
